Rami Kantor

6.1k citations

141 papers · 3.6k indexed · 1 hit paper · h-index 30

Co-authors: David Katzenstein Robert W. Shafer Ricardo Camacho Jonathan Schapiro Allison DeLong Anne–Mieke Vandamme Soo‐Yon Rhee Philip A. Chan
Topics: HIV Research and Treatment (98 papers)HIV/AIDS Research and Interventions (96 papers)HIV/AIDS drug development and treatment (80 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: JAMA Nucleic Acids Research Bioinformatics
Partner nations: United States Kenya Israel

In The Last Decade

Rami Kantor

130 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

2009 731 citations Diane Bennett, Rami Kantor et al. profile →

Peers

Countries citing papers authored by Rami Kantor

Since Specialization

Citations

This map shows the geographic impact of Rami Kantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rami Kantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rami Kantor more than expected).

Fields of papers citing papers by Rami Kantor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rami Kantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rami Kantor. The network helps show where Rami Kantor may publish in the future.

Co-authorship network of co-authors of Rami Kantor

This figure shows the co-authorship network connecting the top 25 collaborators of Rami Kantor. A scholar is included among the top collaborators of Rami Kantor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rami Kantor. Rami Kantor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants 2024 ·AIDS and Behavior ·José E. Diaz,(unknown),(unknown),Soya S. Sam,Rami Kantor,(unknown),(unknown),(unknown),Raymond R. Balise,(unknown),(unknown),Keith J. Horvath,Adam W. Carrico,Sabina Hirshfield	1
2	An Automated Bioinformatics Pipeline Informing Near-Real-Time Public Health Responses to New HIV Diagnoses in a Statewide HIV Epidemic 2023 ·Viruses ·Mark Howison,Fizza S. Gillani,Vlad Novitsky,Jon A. Steingrimsson,John P Fulton,Thomas Bertrand,(unknown),(unknown),(unknown),(unknown),(unknown),Joel Hague,Casey W. Dunn,Utpala Bandy,Joseph W. Hogan,Rami Kantor	7
3	Characterization of HIV-Related Stigma in Myanmar 2023 ·AIDS and Behavior ·Su Aung,Nicole Hardy,Joseph W. Hogan,Allison DeLong,(unknown),(unknown),(unknown),Rami Kantor	3
4	Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan Youth 2023 ·Viruses ·Vlad Novitsky,Winstone Nyandiko,Rachel Vreeman,Allison DeLong,Mark Howison,Akarsh Manne,Josephine Aluoch,(unknown),(unknown),(unknown),(unknown),(unknown),Joseph W. Hogan,Rami Kantor	3
5	HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C. 2021 ·AIDS Research and Human Retroviruses ·Curt G. Beckwith,(unknown),Akarsh Manne,Vladimir Novitsky,Mark Howison,Tao Liu,Irene Kuo,Ann Kurth,Lauri Bazerman,(unknown),Rami Kantor	1
6	SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States 2020 ·Journal of the International AIDS Society ·(unknown),Curt G. Beckwith,Joseph Garland,Jennie Johnson,Su Aung,Susan Cu‐Uvin,Dimitrios Farmakiotis,Timothy Flanigan,Fizza S. Gillani,Raul Macias Gil,Maria D. Mileno,Bharat Ramratnam,Natasha Rybak,(unknown),Karen T. Tashima,Eleftherios Mylonakis,Rami Kantor	48
7	Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium 2020 ·Viruses ·Hezhao Ji,Paul Sandstrom,Roger Paredes,P. Richard Harrigan,Chanson J. Brumme,Santiago Ríos,Marc Noguera-Julián,Neil Parkin,Rami Kantor	19
8	Comparison of machine learning methods for predicting viral failure: a case study using electronic health record data 2020 ·PubMed ·(unknown),(unknown),Allison DeLong,Stavroula A. Chrysanthopoulou,Rami Kantor,Joseph W. Hogan	1
9	Challenges in evaluating the use of viral sequence data to identify HIV transmission networks for public health 2020 ·PubMed ·Rami Kantor,John P Fulton,Jon A. Steingrimsson,Vladimir Novitsky,Mark Howison,Fizza S. Gillani,Yuanning Li,Akarsh Manne,(unknown),Matthew A. Spence,(unknown),Philip A. Chan,Casey W. Dunn,Thomas Bertrand,Utpala Bandy,Nicole Alexander‐Scott,Joseph W. Hogan	3
10	Measurement error and variant-calling in deep Illumina sequencing of HIV 2018 ·Bioinformatics ·Mark Howison,Mia Coetzer,Rami Kantor	20
11	Risk group characteristics and viral transmission clusters in South‐East Asian patients infected with human immunodeficiency virus‐1 (HIV‐1) circulating recombinant form (CRF) 01_AE and subtype B 2015 ·The Kaohsiung Journal of Medical Sciences ·Rebecca Oyomopito,Yen‐Ju Chen,(unknown),Somnuek Sungkanuparph,Rami Kantor,Tuti Parwati Merati,W C Yam,Thira Sirisanthana,Patrick CK Li,Pacharee Kantipong,Praphan Phanuphak,(unknown),Adeeba Kamarulzaman,Rossana Ditangco,Szu‐Wei Huang,Annette H. Sohn,Matthew Law,(unknown),(unknown)	2
12	Extensive Drug Resistance in HIV-Infected Cambodian Children Who Are Undetected as Failing First-Line Antiretroviral Therapy by WHO 2010 Guidelines 2013 ·AIDS Research and Human Retroviruses ·Mia Coetzer,(unknown),Allison DeLong,(unknown),(unknown),Eric Nerrienet,(unknown),Rami Kantor	9
13	QColors: An algorithm for conservative viral quasispecies reconstruction from short and non-contiguous next generation sequencing reads 2012 ·In Silico Biology ·Austin Huang,Rami Kantor,Allison DeLong,(unknown),Sorin Istrail	16
14	Unusual Insertion and Deletion at Codon 67 and 69 of HIV Type 1 Subtype C Reverse Transcriptase Among First-Line Highly Active Antiretroviral Treatment-Failing South Indian Patients: Association with Other Resistance Mutations 2012 ·AIDS Research and Human Retroviruses ·Shanmugam Saravanan,Vidya Madhavan,Rami Kantor,(unknown),(unknown),Sunil S. Solomon,Nagalingeswaran Kumarasamy,Davey M. Smith,Robert T. Schooley,Suniti Solomon,Pachamuthu Balakrishnan	5
15	Short Communication: New HIV Infections at Southern New England Academic Institutions: Implications for Prevention 2012 ·AIDS Research and Human Retroviruses ·Philip A. Chan,(unknown),Aadia Rana,(unknown),(unknown),Kenneth H. Mayer,(unknown),(unknown),Fizza S. Gillani,Nicole Alexander,(unknown),Timothy Flanigan,Rami Kantor	12
16	Darunavir Is a Good Third-Line Antiretroviral Agent for HIV Type 1-Infected Patients Failing Second-Line Protease Inhibitor-Based Regimens in South India 2012 ·AIDS Research and Human Retroviruses ·Shanmugam Saravanan,Vidya Madhavan,Pachamuthu Balakrishnan,Davey M. Smith,Sunil S. Solomon,(unknown),Selvamuthu Poongulali,Nagalingeswaran Kumarasamy,Robert T. Schooley,Suniti Solomon,Rami Kantor	6
17	Sequence Quality Analysis Tool for HIV Type 1 Protease and Reverse Transcriptase 2011 ·AIDS Research and Human Retroviruses ·Allison DeLong,(unknown),Diane Bennett,Neil Parkin,Zhijin Wu,Joseph W. Hogan,Rami Kantor	31
18	High Frequency of Clinically Significant Mutations after First‐Line Generic Highly Active Antiretroviral Therapy Failure: Implications for Second‐Line Options in Resource‐Limited Settings 2009 ·Clinical Infectious Diseases ·N. Kumarasamy,Vidya Madhavan,Kartik K. Venkatesh,Shanmugam Saravanan,Rami Kantor,Pachamuthu Balakrishnan,(unknown),Selvamuthu Poongulali,(unknown),Suniti Solomon,(unknown),Constance A. Benson,Robert T. Schooley	55
19	Drug Resistance in Plasma and Breast Milk after Single-Dose Nevirapine in Subtype C HIV Type 1: Population and Clonal Sequence Analysis 2007 ·AIDS Research and Human Retroviruses ·Seble Kassaye,Esther Lee,Rami Kantor,Elizabeth Johnston,Mark A. Winters,Lynn S. Zijenah,(unknown),David Katzenstein	27
20	HIV-1 Subtype C Reverse Transcriptase and Protease Genotypes in Zimbabwean Patients Failing Antiretroviral Therapy 2002 ·AIDS Research and Human Retroviruses ·Rami Kantor,Lynn S. Zijenah,Robert W. Shafer,(unknown),Elizabeth Johnston,Robert M. Lloyd,(unknown),Dennis Israelski,David Katzenstein	50

About Rami Kantor

Rami Kantor is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 141 papers that have together received 3.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (98 papers), HIV/AIDS Research and Interventions (96 papers) and HIV/AIDS drug development and treatment (80 papers). The work is most often cited by research in Virology (2.7k citations), Infectious Diseases (3.0k citations) and Hepatology (161 citations). Rami Kantor has collaborated with scholars based in United States, Kenya and Israel. Frequent co-authors include David Katzenstein, Robert W. Shafer, Ricardo Camacho, Jonathan Schapiro, Allison DeLong, Anne–Mieke Vandamme, Soo‐Yon Rhee, Philip A. Chan, Paul Sandstrom and Diane Bennett. Their work appears in journals such as JAMA, Nucleic Acids Research and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact